Nyxoah (NYXH) - Net Assets

Latest as of September 2025: €50.95 Million EUR ≈ $59.57 Million USD

Based on the latest financial reports, Nyxoah (NYXH) has net assets worth €50.95 Million EUR (≈ $59.57 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€93.60 Million ≈ $109.43 Million USD) and total liabilities (€42.65 Million ≈ $49.86 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Nyxoah liquidity resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	€50.95 Million
% of Total Assets	54.44%
Annual Growth Rate	58.39%
5-Year Change	16.53%
10-Year Change	N/A
Growth Volatility	877.2

Nyxoah - Net Assets Trend (2017–2024)

This chart illustrates how Nyxoah's net assets have evolved over time, based on quarterly financial data. Also explore Nyxoah balance sheet assets for the complete picture of this company's asset base.

Annual Net Assets for Nyxoah (2017–2024)

The table below shows the annual net assets of Nyxoah from 2017 to 2024. For live valuation and market cap data, see NYXH market cap overview.

Year	Net Assets	Change
2024-12-31	€113.25 Million ≈ $132.41 Million	+15.54%
2023-12-31	€98.02 Million ≈ $114.60 Million	-18.53%
2022-12-31	€120.32 Million ≈ $140.67 Million	-19.04%
2021-12-31	€148.62 Million ≈ $173.75 Million	+52.92%
2020-12-31	€97.19 Million ≈ $113.63 Million	+2517.56%
2019-12-31	€3.71 Million ≈ $4.34 Million	-64.48%
2018-12-31	€10.45 Million ≈ $12.22 Million	+130.93%
2017-12-31	€4.53 Million ≈ $5.29 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Nyxoah's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 18700000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Other Components	€330.99 Million	292.25%
Total Equity	€113.25 Million	100.00%

Nyxoah Competitors by Market Cap

The table below lists competitors of Nyxoah ranked by their market capitalization.

Company	Market Cap
Woorim Machinery Co. Ltd KQ:101170	$127.28 Million
Easy Field TWO:6425	$127.30 Million
Business Online PCL BK:BOL	$127.36 Million
Pyrum Innovations AG OL:PYRUM	$127.38 Million
Bellevue Group AG SW:BBN	$127.19 Million
Alpha Cognition Inc NASDAQ:ACOG	$127.19 Million
Aesler Grup Internasional Tbk Pt JK:RONY	$127.08 Million
HYUNDAI FEED Inc KQ:016790	$126.96 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Nyxoah's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 98,022,000 to 113,254,000, a change of 15,232,000 (15.5%).
Net loss of 59,236,000 reduced equity.
New share issuances of 69,722,000 increased equity.
Other factors increased equity by 4,746,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	€-59.24 Million	-52.3%
Share Issuances	€69.72 Million	+61.56%
Other Changes	€4.75 Million	+4.19%
Total Change	€-	15.54%

Book Value vs Market Value Analysis

This analysis compares Nyxoah's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.84x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 11.68x to 0.84x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-12-31	€0.22	€2.53	x
2018-12-31	€0.50	€2.53	x
2019-12-31	€0.18	€2.53	x
2020-12-31	€4.40	€2.53	x
2021-12-31	€5.77	€2.53	x
2022-12-31	€4.66	€2.53	x
2023-12-31	€3.42	€2.53	x
2024-12-31	€3.03	€2.53	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Nyxoah utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -52.30%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -1310.24%
• Asset Turnover: 0.03x
• Equity Multiplier: 1.40x
Recent ROE (-52.30%) is above the historical average (-83.11%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2017	-229.09%	0.00%	0.00x	2.46x	€-10.82 Million
2018	-86.85%	0.00%	0.00x	1.72x	€-10.12 Million
2019	-195.39%	0.00%	0.00x	4.09x	€-7.63 Million
2020	-12.60%	-17746.38%	0.00x	1.17x	€-21.96 Million
2021	-18.58%	-3241.67%	0.00x	1.15x	€-42.48 Million
2022	-25.95%	-1012.48%	0.02x	1.21x	€-43.26 Million
2023	-44.08%	-993.84%	0.04x	1.27x	€-53.01 Million
2024	-52.30%	-1310.24%	0.03x	1.40x	€-70.56 Million

Industry Comparison

This section compares Nyxoah's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

No peer company data available for comparison.

About Nyxoah

BR:NYXH Belgium Medical Instruments & Supplies

Market Cap

$127.27 Million

€108.86 Million EUR

Market Cap Rank

#18262 Global

#80 in Belgium

Share Price

€2.53

Change (1 day)

+1.20%

52-Week Range

€2.40 - €7.70

All Time High

€29.90